Ellen Weisberg and Martin Sattler (2012) “A novel combination therapy approach for the treatment of acute myeloid leukemia: the multi-kinase inhibitor sorafenib and the HDM2 inhibitor nutlin-3”, Haematologica. Pavia, Italy, 97(11), pp. 1620-1621. doi: 10.3324/haematol.2012.078451.